ReviewInternational immunopharmacology2021

Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.

Ilad Alavi Darazam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.